Vometinib mesylate tablets, a Western medicine name. It is a protein kinase inhibitor. It is used to treat adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have experienced disease progression during or after treatment with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) and have been confirmed to have EGFR T790M mutation-positive disease.
Let us work together to protect precious health